Clinical Trials Logo

Clinical Trial Summary

Currently the most use solution to volemic reposition in hip replacement arthroplasty is the crystalloid solution. This trial intends to compare two different volemic replacements: HES and Ringer's lactate. This research has been analyzing hemodynamic parameters and the coagulation status before and after the pre-expansion with the solutions above mentioned.


Clinical Trial Description

This trial is randomized an blind to the physician who is analyzing the results.It has been select adults; both sex; ASA I and II. These patients must be submitted to hip arthroplasty replacement. The anesthesia technique is single shot spinal anesthesia. Primary endpoint: assessment alternative; technique replacement volemic with HES 130/04. Secondary endpoint: haemostatic abnormalities; blood loss; transfusion blood. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00542516
Study type Interventional
Source University of Sao Paulo
Contact
Status Completed
Phase Phase 4
Start date September 2006
Completion date November 2008

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03505580 - AMIStem-H Radiological Assessment
Completed NCT02162121 - Stimulating Catheter for Lumbar Plexus Block: Better Postoperative Analgesia? Phase 4
Active, not recruiting NCT03724058 - Fixation and Stability of the Trident® II Clusterhole HA Shells N/A
Recruiting NCT02346513 - Serum Level of Cobalt and Chromium After Ceramic on Metal Articulation Total Hip Arthroplasty N/A
Completed NCT01394744 - Determination of Metal Ion Serum Levels and Cytokines in Total Hip Replacement